---
title: Publications
layout: page
---

# Out

**Melloni GEM**, Guida A, Curigliano G, Botteri E, Esposito A, Kamal M, Le Torneau C, Riva L, Pelicci PG and Mazzarella L. Precision Trial Drawer (PTD): a computational tool to assist planning of genomics-driven trials in oncology (accepted in *JCO – Precision Oncology*)

**GEM Melloni**, G. Ukmar, L. Raddrizzani, P. Rossi, S. Di Bella, M. R. Pirchio, M. Vescovi, A. Leone, M. Callari, M. Cesarini, A. Somaschini, G. Della Vedova, MG Daidone, M. Pettenella, A. Isacchi, and R. Bosotti PATRI, a Genomics Data Integration Tool for Biomarker Discovery *BioMed Research International* (2018), Article ID 2012078 https://doi.org/10.1155/2018/2012078

Gilly A, Suveges D, Kuchenbaecker K, Pollard M, Southam L, Hatzikotoulas K, Farmaki AE, Bjornland T, Waples R, Appel EVR, Casalone E, **Melloni G**, Killian B, Rayner NW, Ntallia I, Kundu K, Walter K, Danesh J, Butterworth A, Barroso I, Tsafantakis E, Dedoussis G, Moltke I, Zeggini E Cohort-wide deep whole genome sequencing and the allelic architecture of complex traits *bioRxiv* (2018) doi: https://doi.org/10.1101/283481

Gilly A, Kuchenbaecker K, Southam L, Suveges D, Moore R, **Melloni G**, Hatzikotoulas K, Farmaki AE, Ritchie G, Schwartzentruber J, Danecek P, Kilian B, Pollard M, Ge X, Elding H, Astle W, Jiang T, Butterworth A, Soranzo N, Tsafantakis E, Karaleftheri M, Dedoussis G, Zeggini E Very low depth whole genome sequencing in complex trait association studies, bioRxiv (2017) doi: https://doi.org/10.1101/169789 [](http://www.biorxiv.org/content/early/2017/07/28/169789) )

Sanarico AG, Ronchini C, Croce A, Memmi E, Cammarata UA, De Antoni A, Larvogna S, Divona M, Giacò L, **Melloni GEM**, Lo Coco F, Melino G, Pelicci PG and Bernassola F The E3 ubiquitin ligase WWP1 sustains the growth of acute myeloid leukemia. *Leukemia* (2017) http://dx.doi.org/10.1038/leu.2017.342

Richichi C, Fornasari L, **Melloni GEM**, Brescia P, Patanè M, Del Bene M, Mustafa DAM, Kros JM, Pollo B, Pruneri G, Sciandivasci A, Munzone E, DiMeco F, Pelicci PG, Riva L, Pelicci G. Mutations targeting the coagulation pathway are enriched in brain metastases *Scientific Reports* 7, Article number: 6573 (2017) doi:10.1038/s41598-017-06811-x

**Melloni GEM**, Mazzarella L, Russo A, Bodini M, Bernard L, Luzi L, Pelicci PG and Riva L, A knowledge based computational framework for breast cancer predisposing gene discovery using exome sequencing data *Breast Cancer Research* 2017 19:63 doi: 10.1186/s13058-017-0854-1

Ronchini C, Brozzi A, Riva L, Luzi L, Gruszka A, Scanziani E, **Melloni GE**, Dharmalingam G, Mutarelli M, Belcastro V, Lavorgna S, Rossi V, Spinelli O, Biondi A, Rambaldi A, Lo-Coco F, di Bernardo D, Pelicci PG. PML-RARA—associated cooperating mutations belong to a transcriptional network that is deregulated in myeloid leukemias *Leukemia*. 2016 Dec 27. doi: 10.1038/leu.2016.386

Daniela Bossi, Angelo Cicalese, Gaetano I. Dellino, Lucilla Luzi, Laura Riva, Carolina D'Alesio, Giuseppe R. Diaferia, Alessandro Carugo, Elena Cavallaro, Rossana Piccioni, Massimo Barberis, Giovanni Mazzarol, Alessandro Testori, Simona Punzi, Isabella Pallavicini, Giulio Tosti, Luciano Giacó, **Giorgio Melloni**, Timothy P. Heffernan, Gioacchino Natoli, Giulio F. Draetta, Saverio Minucci, PierGiuseppe Pelicci and Luisa Lanfrancone In Vivo Genetic Screens of Patient-Derived Tumors Revealed Unexpected Frailty of the Transformed Phenotype *Cancer Discov* May 13, 2016; 
doi: 10.1158/2159-8290.CD-15-1200

**Melloni GE**, de Pretis S, Riva L, Pelizzola M, Céol A, Costanza J, Müller H, Zammataro L LowMACA: exploiting protein family analysis for the identification of rare driver mutations in cancer. *BMC Bioinformatics*. 2016 Feb 9;17(1):80. doi: 10.1186/s12859-016-0935-7.

de Pretis S, Kress T, Morelli MJ, **Melloni GE,** Riva L, Amati B, Pelizzola M. INSPEcT: a Computational Tool to Infer mRNA Synthesis, Processing and Degradation Dynamics from RNA- and 4sU-seq Time Course Experiments , *Bioinformatics* (2015) doi:10.1093/bioinformatics/btv288

Bodini M, Ronchini C, Giacò L, Russo A, **Melloni GEM**, Luzi L, Sardella D, Volorio S, Hasan SK, Ottone T, Lavorgna S, Lo-Coco F, Candoni A, Fanin R, Toffoletti E, Iacobucci I, Martinelli G, Cignetti A, Tarella C, Bernard L, Pelicci PG, and Riva L. The hidden genomic landscape of acute myeloid leukemia: subclonal structure revealed by undetected mutations. *Blood*. 2015 Jan 22;125(4):600-5. doi 10.1182/blood-2014-05-576157

**Melloni GEM**, Ogier AGE, de Pretis S, Mazzarella L, Pelizzola M, Pelicci PG and Riva L. DOTS-Finder: a comprehensive tool for assessing driver genes in cancer genomes. *Genome Medicine* 2014, 6:44, doi: 10.1186/gm563

Riva L, Ronchini C, Bodini M, Lo-Coco F, Lavorgna S, Ottone T, Martinelli G, Iacobucci I, Tarella C, Cignetti A, Volorio S, Bernard L, Russo A, **Melloni GEM**, Luzi L, Alcalay M, Dellino GI, Pelicci PG. Acute promyelocytic leukemias share cooperative mutations with other myeloid-leukemia subgroups. *Blood Cancer Journal* 2013 Sep 13;3:e147. doi: 10.1038/bcj.2013.46.

# On the run

Dellino G, Palluzzi F, Piccioni R, Furia L, **Melloni GEM**, Guido D, Giacò L, Luzi L, Cittaro D, Faretta M, Crosetto N and Pelicci PG. Unresolved Double Strand Breaks in normal mammary cells are enriched at specific promoter regions and overlap with breakpoints of breast-cancer associated translocations (submitted)

Santoro A, Vlachou T, Luzi L, Pasi C, Reavie L, **Melloni G**, Bonetti P, D'Elia E, Casoli L, Sabò A, Nicassio F, Moroni M, Dellino G, Amati, B, Pelicci PG. Loss of p53 in breast cancer leads to Myc activation and reprogramming of cancer stem cells (under review in *Cell Reports*)
